Ramucirumab as Second-Line Systemic Therapy in Hepatocellular Carcinoma

समान संसाधन

• Cabozantinib as a Second-Line Agent in Advanced Hepatocellular Carcinoma
  द्वारा: Kudo, Masatoshi
  प्रकाशित: (2018)
• Regorafenib as Second-Line Systemic Therapy May Change the Treatment Strategy and Management Paradigm for Hepatocellular Carcinoma
  द्वारा: Kudo, M.
  प्रकाशित: (2016)
• Second-line ramucirumab therapy for advanced hepatocellular carcinoma (REACH): an East Asian and non-East Asian subgroup analysis
  द्वारा: Park, Joon Oh, और अन्य
  प्रकाशित: (2016)
• Second line systemic therapies for hepatocellular carcinoma: Reasons for the failure
  द्वारा: Maida, Marcello, और अन्य
  प्रकाशित: (2015)
• Better Efficacy of Ramucirumab in Japanese Patients than in the Global Population with Unresectable Hepatocellular Carcinoma
  द्वारा: Kudo, Masatoshi
  प्रकाशित: (2020)